Half of all drugmakers failed to alert the FDA about quality issues with products shipped between 2018 and 2021, according to Axios. Field alert reports (FARs) are not a required reporting measure, but help regulators assess risk to the public and how well companies manage issues. Out of 1,143 sites eligible to submit FARs, the FDA found that only 49.1 percent actually did over a four-year period.
Related Posts
Drugmaker settles monopoly lawsuits
Indivior has agreed to pay $385 million to settle a class action lawsuit from drug wholesalers who claim that the drugmaker illegally stifled competition…
Decorating for fall It’s fun to build a scarecrow: Here’s how
It’s too late to celebrate Build a Scarecrow Day. That was July 5th, but it was for gardeners and farmers. That was also Workaholic’s Day, so building a…
Study: Daily aspirin might increase risk of brain bleeds
Daily low-dose aspirin does little to prevent first heart attacks or stroke, but may increase the risk of bleeding inside the skull in older adults,…